Abubaker K - Search Results

1

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N. Abubaker K, et al. BMC Cancer. 2014 May 6;14:317. doi: 10.1186/1471-2407-14-317. BMC Cancer. 2014. PMID: 24886434 Free PMC article.

2

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

Ahmed N, Abubaker K, Findlay J, Quinn M. Ahmed N, et al. Among authors: abubaker k. Curr Cancer Drug Targets. 2010 May;10(3):268-78. doi: 10.2174/156800910791190175. Curr Cancer Drug Targets. 2010. PMID: 20370691 Review.

3

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N. Latifi A, et al. Among authors: abubaker k. J Cell Biochem. 2011 Oct;112(10):2850-64. doi: 10.1002/jcb.23199. J Cell Biochem. 2011. PMID: 21618587

4

Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.

Ahmed N, Abubaker K, Findlay J, Quinn M. Ahmed N, et al. Among authors: abubaker k. J Cell Biochem. 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. J Cell Biochem. 2013. PMID: 22887554 Review.

5

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.

Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, Thompson EW, Findlay JK, Ahmed N. Abubaker K, et al. Mol Cancer. 2013 Mar 27;12:24. doi: 10.1186/1476-4598-12-24. Mol Cancer. 2013. PMID: 23537295 Free PMC article.

6

Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.

Ahmed N, Abubaker K, Findlay JK. Ahmed N, et al. Among authors: abubaker k. Mol Aspects Med. 2014 Oct;39:110-25. doi: 10.1016/j.mam.2013.06.002. Epub 2013 Jun 25. Mol Aspects Med. 2014. PMID: 23811037 Review.

7

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.

Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK, Ahmed N. Abubaker K, et al. Front Oncol. 2014 Apr 9;4:75. doi: 10.3389/fonc.2014.00075. eCollection 2014. Front Oncol. 2014. PMID: 24782986 Free PMC article.

8

Antimicrobial susceptibility and integrons detection among extended-spectrum β-lactamase producing Enterobacteriaceae isolates in patients with urinary tract infection.

Abubaker KT, Anwar KA. Abubaker KT, et al. PeerJ. 2023 Jun 2;11:e15429. doi: 10.7717/peerj.15429. eCollection 2023. PeerJ. 2023. PMID: 37283901 Free PMC article.

9

Induction of lcc2 expression and activity by Agaricus bisporus provides defence against Trichoderma aggressivum toxic extracts.

Sjaarda CP, Abubaker KS, Castle AJ. Sjaarda CP, et al. Among authors: abubaker ks. Microb Biotechnol. 2015 Nov;8(6):918-29. doi: 10.1111/1751-7915.12277. Epub 2015 Mar 30. Microb Biotechnol. 2015. PMID: 25824278 Free PMC article.

10

Up close: family therapy challenges and innovations around the world.

Roberts J, Abu-Baker K, Diez Fernández C, Chong Garcia N, Fredman G, Kamya H, Martín Higarza Y, Fortes de Leff J, Messent P, Nakamura S, Torun Reid F, Sim T, Subrahmanian C, Zevallos Vega R. Roberts J, et al. Fam Process. 2014 Sep;53(3):544-76. doi: 10.1111/famp.12093. Epub 2014 Aug 7. Fam Process. 2014. PMID: 25099431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters